Literature DB >> 31434731

Novel Functions of IFI44L as a Feedback Regulator of Host Antiviral Responses.

Marta L DeDiego1,2,3, Luis Martinez-Sobrido2, David J Topham4,2.   

Abstract

We describe a novel function for the interferon (IFN)-induced protein 44-like (IFI44L) gene in negatively modulating innate immune responses induced after virus infections. Furthermore, we show that decreasing IFI44L expression impairs virus production and that IFI44L expression negatively modulates the antiviral state induced by an analog of double-stranded RNA (dsRNA) or by IFN treatment. The mechanism likely involves the interaction of IFI44L with cellular FK506-binding protein 5 (FKBP5), which in turn interacts with kinases essential for type I and III IFN responses, such as inhibitor of nuclear factor kappa B (IκB) kinase alpha (IKKα), IKKβ, and IKKε. Consequently, binding of IFI44L to FKBP5 decreased interferon regulatory factor 3 (IRF-3)-mediated and nuclear factor kappa-B (NF-κB) inhibitor (IκBα)-mediated phosphorylation by IKKε and IKKβ, respectively. According to these results, IFI44L is a good target for treatment of diseases associated with excessive IFN levels and/or proinflammatory responses and for reduction of viral replication.IMPORTANCE Excessive innate immune responses can be deleterious for the host, and therefore, negative feedback is needed. Here, we describe a completely novel function for IFI44L in negatively modulating innate immune responses induced after virus infections. In addition, we show that decreasing IFI44L expression impairs virus production and that IFI44L expression negatively modulates the antiviral state induced by an analog of dsRNA or by IFN treatment. IFI44L binds to the cellular protein FKBP5, which in turn interacts with kinases essential for type I and III IFN induction and signaling, such as the kinases IKKα, IKKβ, and IKKε. IFI44L binding to FKBP5 decreased the phosphorylation of IRF-3 and IκBα mediated by IKKε and IKKβ, respectively, providing an explanation for the function of IFI44L in negatively modulating IFN responses. Therefore, IFI44L is a candidate target for reducing virus replication.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  FKBP5; IFI44L; IKK kinase activity; IKKβ kinase activity; IKKε kinase activity; IRF-3 phosphorylation; IκBα phosphorylation; antiviral responses; innate immunity; interferon-induced protein; signaling transduction; type I and III interferon responses

Mesh:

Substances:

Year:  2019        PMID: 31434731      PMCID: PMC6803278          DOI: 10.1128/JVI.01159-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  72 in total

1.  Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43.

Authors:  Magdalena Sarasin-Filipowicz; Xueya Wang; Ming Yan; Francois H T Duong; Valeria Poli; Douglas J Hilton; Dong-Er Zhang; Markus H Heim
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

2.  Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300.

Authors:  M Yoneyama; W Suhara; Y Fukuhara; M Fukuda; E Nishida; T Fujita
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

Review 3.  Overlapping and distinct mechanisms regulating IRF-3 and IRF-7 function.

Authors:  Marc J Servant; Benjamin Tenoever; Rongtuan Lin
Journal:  J Interferon Cytokine Res       Date:  2002-01       Impact factor: 2.607

4.  Influenza A Virus Protein PA-X Contributes to Viral Growth and Suppression of the Host Antiviral and Immune Responses.

Authors:  Tsuyoshi Hayashi; Leslie A MacDonald; Toru Takimoto
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

Review 5.  Putting the brakes on the anti-viral response: negative regulators of type I interferon (IFN) production.

Authors:  Kathryn H Richards; Andrew Macdonald
Journal:  Microbes Infect       Date:  2011-01-20       Impact factor: 2.700

Review 6.  Plasmid-only rescue of influenza A virus vaccine candidates.

Authors:  J H Schickli; A Flandorfer; T Nakaya; L Martinez-Sobrido; A García-Sastre; P Palese
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

7.  IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes.

Authors:  Pamela I Osterlund; Taija E Pietilä; Ville Veckman; Sergei V Kotenko; Ilkka Julkunen
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

8.  A diverse range of gene products are effectors of the type I interferon antiviral response.

Authors:  John W Schoggins; Sam J Wilson; Maryline Panis; Mary Y Murphy; Christopher T Jones; Paul Bieniasz; Charles M Rice
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

9.  Mitochondria-nucleus shuttling FK506-binding protein 51 interacts with TRAF proteins and facilitates the RIG-I-like receptor-mediated expression of type I IFN.

Authors:  Taishin Akiyama; Takuma Shiraishi; Junwen Qin; Hiroyasu Konno; Nobuko Akiyama; Miho Shinzawa; Maki Miyauchi; Nobukazu Takizawa; Hiromi Yanai; Hiroyuki Ohashi; Etsuko Miyamoto-Sato; Hiroshi Yanagawa; Weidong Yong; Weinian Shou; Jun-Ichiro Inoue
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

10.  Identification of the Mechanisms Causing Reversion to Virulence in an Attenuated SARS-CoV for the Design of a Genetically Stable Vaccine.

Authors:  Jose M Jimenez-Guardeño; Jose A Regla-Nava; Jose L Nieto-Torres; Marta L DeDiego; Carlos Castaño-Rodriguez; Raul Fernandez-Delgado; Stanley Perlman; Luis Enjuanes
Journal:  PLoS Pathog       Date:  2015-10-29       Impact factor: 6.823

View more
  21 in total

1.  Vitamin D deficiency after allogeneic hematopoietic cell transplantation promotes T-cell activation and is inversely associated with an EZH2-ID3 signature.

Authors:  Rodney Macedo; Chloé Pasin; Alex Ganetsky; David Harle; Ximi K Wang; Kirubel Belay; Lee P Richman; Austin P Huffman; Robert H Vonderheide; Andrew J Yates; David L Porter; Ying Wang; Yi Zhang; Ran Reshef
Journal:  Transplant Cell Ther       Date:  2021-09-28

2.  PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine.

Authors:  Ramin Sedaghat Herati; David A Knorr; Laura A Vella; Luisa Victoria Silva; Lakshmi Chilukuri; Sokratis A Apostolidis; Alexander C Huang; Alexander Muselman; Sasikanth Manne; Oliva Kuthuru; Ryan P Staupe; Sharon A Adamski; Senthil Kannan; Raj K Kurupati; Hildegund C J Ertl; Jeffrey L Wong; Stylianos Bournazos; Suzanne McGettigan; Lynn M Schuchter; Ritesh R Kotecha; Samuel A Funt; Martin H Voss; Robert J Motzer; Chung-Han Lee; Dean F Bajorin; Tara C Mitchell; Jeffrey V Ravetch; E John Wherry
Journal:  Nat Immunol       Date:  2022-07-28       Impact factor: 31.250

3.  EWAS of post-COVID-19 patients shows methylation differences in the immune-response associated gene, IFI44L, three months after COVID-19 infection.

Authors:  Yunsung Lee; Espen Riskedal; Karl Trygve Kalleberg; Mette Istre; Andreas Lind; Fridtjof Lund-Johansen; Olaug Reiakvam; Arne V L Søraas; Jennifer R Harris; John Arne Dahl; Cathrine L Hadley; Astanand Jugessur
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

4.  Differentially methylation of IFI44L gene promoter in Iranian patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Mansour Salesi; Milad Hayeri Dehabadi; Rasoul Salehi; Amirhossein Salehi; Bahram Pakzad
Journal:  Mol Biol Rep       Date:  2022-01-20       Impact factor: 2.316

5.  Bioinformatic Analysis Reveals Hub Immune-Related Genes of Diabetic Foot Ulcers.

Authors:  Yanchao Rong; Hao Yang; Hailin Xu; Shuting Li; Peng Wang; Zhiyong Wang; Yi Zhang; Wenkai Zhu; Bing Tang; Jiayuan Zhu; Zhicheng Hu
Journal:  Front Surg       Date:  2022-04-05

6.  Interferon-Induced Protein 44 and Interferon-Induced Protein 44-Like Restrict Replication of Respiratory Syncytial Virus.

Authors:  D C Busse; D Habgood-Coote; S Clare; C Brandt; I Bassano; M Kaforou; J Herberg; M Levin; J-F Eléouët; P Kellam; J S Tregoning
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

7.  Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression.

Authors:  Guohe Song; Yang Shi; Meiying Zhang; Shyamal Goswami; Saifullah Afridi; Lu Meng; Jiaqiang Ma; Yi Chen; Youpei Lin; Juan Zhang; Yuming Liu; Zijie Jin; Shuaixi Yang; Dongning Rao; Shu Zhang; Aiwu Ke; Xiaoying Wang; Ya Cao; Jian Zhou; Jia Fan; Xiaoming Zhang; Ruibin Xi; Qiang Gao
Journal:  Cell Discov       Date:  2020-12-08       Impact factor: 10.849

8.  Expression of USP18 and IL2RA Is Increased in Individuals Receiving Latent Tuberculosis Treatment with Isoniazid.

Authors:  Eleane de Oyarzabal; Lourdes García-García; Claudia Rangel-Escareño; Leticia Ferreyra-Reyes; Lorena Orozco; María Teresa Herrera; Claudia Carranza; Eduardo Sada; Esmeralda Juárez; Alfredo Ponce-de-León; José Sifuentes-Osornio; Robert J Wilkinson; Martha Torres
Journal:  J Immunol Res       Date:  2019-12-06       Impact factor: 4.818

9.  Innate Lymphoid Cells Activation and Transcriptomic Changes in Response to Human Dengue Infection.

Authors:  Tiraput Poonpanichakul; Wilawan Chan-In; Anunya Opasawatchai; Fabien Loison; Oranart Matangkasombut; Varodom Charoensawan; Ponpan Matangkasombut
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

10.  Identification of potential biomarkers in dengue via integrated bioinformatic analysis.

Authors:  Li-Min Xie; Xin Yin; Jie Bi; Huan-Min Luo; Xun-Jie Cao; Yu-Wen Ma; Ye-Ling Liu; Jian-Wen Su; Geng-Ling Lin; Xu-Guang Guo
Journal:  PLoS Negl Trop Dis       Date:  2021-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.